Cancer screening tests — including the prostate-specific antigen (PSA) test to look for signs of prostate cancer — can be a good idea.
Prostate cancer screening can help identify cancer early on, when treatment is most effective. And a normal PSA test, combined with a digital rectal exam, can help reassure you that it’s unlikely you have prostate cancer.
But getting a PSA test for prostate cancer may not be necessary for some men, especially men 70 and older.
Professional organizations vary in their recommendations about who should — and who shouldn’t — get a PSA screening test. While some have definitive guidelines, others leave the decision up to men and their doctors. Organizations that do recommend PSA screening generally encourage the test in men between the ages of 50 and 70, and in men with an increased risk of prostate cancer.
Ultimately, whether you should undergo a PSA test is something you should decide after discussing it with your doctor, considering your risk factors and weighing your personal preferences.
Here’s more information to help you prepare for a conversation with your doctor about PSA testing.
Prostate-specific antigen (PSA) is a protein produced by both cancerous (malignant) and noncancerous (benign) prostate tissue. PSA helps liquefy the semen. A small amount of PSA normally enters the bloodstream.
Prostate cancer cells usually make more PSA than do benign cells, causing PSA levels in your blood to rise. But PSA levels can also be elevated in men with enlarged or inflamed prostate glands. Therefore, determining what a high PSA score means can be complicated.
Besides the PSA number itself, your doctor will consider a number of other factors to evaluate your PSA scores:
While high PSA levels can be a sign of prostate cancer, a number of conditions other than prostate cancer can cause PSA levels to rise. These other conditions could cause what’s known as a “false-positive” — meaning a result that falsely indicates you might have prostate cancer when you don’t.
Conditions that could lead to an elevated PSA level in men who don’t have prostate cancer include:
False-positives are common. Only about 1 in 4 men with an abnormal PSA test result turns out to have prostate cancer.
Some prostate cancers, particularly those that grow quickly, may not produce much PSA. In this case, you might have what’s known as a “false-negative” — a test result that incorrectly indicates you don’t have prostate cancer when you do.
Because of the complexity of these relating factors, it’s important to have a doctor who is experienced in interpreting PSA levels evaluate your situation.
Detecting certain types of prostate cancer early can be critical. Elevated PSA results may reveal prostate cancer that’s likely to spread to other parts of your body (metastasize), or they may reveal a quick-growing cancer that’s likely to cause other problems.
Early treatment can help catch the cancer before it becomes life-threatening or causes serious symptoms. In some cases, identifying cancer early means you will need less aggressive treatment — thus reducing your risk of certain side effects, such as erectile dysfunction and incontinence.
The PSA test isn’t the only screening tool for prostate cancer. Digital rectal examination (DRE) is another important way to evaluate the prostate and look for signs of cancer.
Your doctor performs the test by inserting a gloved, lubricated finger into your rectum to feel the prostate for bumps or other abnormalities. It’s a quick, safe and easy test.
In addition to checking for signs of prostate cancer, your doctor can use a DRE to check for signs of rectal cancer.
Knowing the risk factors for prostate cancer can help you determine if and when you want to begin prostate cancer screening. The main risk factors include:
The option to have PSA testing begins at age 40 and continues until you’re at the age when your life expectancy is 10 years or fewer. Once you reach that age, the likelihood that a prostate cancer would progress and cause problems during the remainder of your lifetime is small.
If several of your first-degree relatives — father, brothers, sons — have had prostate cancer at an early age, your risk is considered very high.
|American Urological Association (AUA)||The AUA recommends that beginning at age 55, men engage in shared decision-making with their doctors about whether to undergo PSA screening. The AUA doesn’t recommend routine PSA screening for men over age 70, or for any man with less than a 10- to 15-year life expectancy.|
|American Cancer Society (ACS)||The ACS recommends that men consult with their doctors to make a decision about PSA testing. According to the ACS, men should explore the risks and benefits of the PSA test starting at age 50 if they are at average risk of prostate cancer and have at least a 10-year life expectancy, at age 45 if they are at high risk and at age 40 if they are at very high risk (those with several first-degree relatives who had prostate cancer at an early age).|
|U.S. Preventive Services Task Force (USPSTF)||The USPSTF recommends that men ages 55 to 69 discuss the benefits and risks of prostate cancer screening with their doctors. The USPSTF recommends against routine screening in men aged 70 and above.|
|Mayo Clinic||Mayo Clinic recommends offering PSA screening and DRE annually to men ages 50 to 70 with a life expectancy greater than 10 years. Men with risk factors for prostate cancer may need to begin screening earlier.|
A positive PSA test can be a lifesaver for some men, identifying prostate cancer that needs treatment early.
It’s generally a good idea to have PSA testing done if you’re at increased risk of prostate cancer. However, not all men need to have the screening. You may want to think twice if you’re in a group of men unlikely to benefit from it.
After considering the pros and cons of screening, your age, general health and risk factors, your preferences and what the experts say, talk to your doctor. Together you can make the right decision for you.
This article has been adapted from Mayo Clinic and accessible at https://www.mayoclinic.org/diseases-conditions/prostate-cancer/in-depth/prostate-cancer/art-20048087